Fertility and Sterility
Volume 92, Issue 1 , Pages 96-107 , July 2009

Network analyses of differentially expressed proteins in amniotic fluid supernatant associated with abnormal human karyotypes

  • Tzu-Hao Wang, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Lin-Kou Medical Center, Chang Gung Memorial Hospital, Chang Gung University, Tao-Yuan, Taiwan
    • Genomic Medicine Research Core Laboratory, Chang Gung Memorial Hospital, Tao-Yuan, Taiwan
    • ,
  • An-Shine Chao, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Lin-Kou Medical Center, Chang Gung Memorial Hospital, Chang Gung University, Tao-Yuan, Taiwan
    • ,
  • Jen-Kun Chen, Ph.D.

      Affiliations

    • Clinical Proteomics Center, Chang Gung Memorial Hospital, Tao-Yuan, Taiwan
    • ,
  • Angel Chao, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Lin-Kou Medical Center, Chang Gung Memorial Hospital, Chang Gung University, Tao-Yuan, Taiwan
    • ,
  • Yao-Lung Chang, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Lin-Kou Medical Center, Chang Gung Memorial Hospital, Chang Gung University, Tao-Yuan, Taiwan
    • ,
  • Po-Jen Cheng, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Lin-Kou Medical Center, Chang Gung Memorial Hospital, Chang Gung University, Tao-Yuan, Taiwan
    • ,
  • Shuenn-Dyh Chang, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Lin-Kou Medical Center, Chang Gung Memorial Hospital, Chang Gung University, Tao-Yuan, Taiwan
    • ,
  • Hsin-Shih Wang, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Lin-Kou Medical Center, Chang Gung Memorial Hospital, Chang Gung University, Tao-Yuan, Taiwan
    • Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Tao-Yuan, Taiwan
    • Corresponding Author InformationReprint requests: Hsin-Shih Wang, MD., PhD., Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Chang Gung University, 5 Fu-Hsing Street, Tao-Yuan 333, Taiwan (FAX: 886-3-3288252).

Received 31 January 2008 ,Revised 22 April 2008 ,Accepted 15 May 2008.

References 

  1. Brace RA. Amniotic fluid dynamics. In:  Creasy RK,  Resnik R editor. Maternal-fetal medicine: principles and practice. Philadelphia: Saunders; 2004;p. 45–53
  2. Keelan JA, Blumenstein M, Helliwell RJ, Sato TA, Marvin KW, Mitchell MD. Cytokines, prostaglandins and parturition—a review. Placenta. 2003;24:S33–S46
  3. Tsangaris GT, Karamessinis P, Kolialexi A, Garbis SD, Antsaklis A, Mavrou A, et al. Proteomic analysis of amniotic fluid in pregnancies with Down syndrome. Proteomics. 2006;6:4410–4419
  4. Hughes C, Elgasim M, Layfield R, Atiomo W. Genomic and post-genomic approaches to polycystic ovary syndrome—progress so far: mini review. Hum Reprod. 2006;21:2766–2775
  5. McDonald T, Sheng S, Stanley B, Chen D, Ko Y, Cole RN, et al. Expanding the subproteome of the inner mitochondria using protein separation technologies: one- and two-dimensional liquid chromatography and two-dimensional gel electrophoresis. Mol Cell Proteomics. 2006;5:2392–2411
  6. Linke T, Ross AC, Harrison EH. Proteomic analysis of rat plasma by two-dimensional liquid chromatography and matrix-assisted laser desorption ionization time-of-flight mass spectrometry. J Chromatogr A. 2006;1123:160–169
  7. Wang TH, Chang YL, Peng HH, Wang ST, Lu HW, Teng SH, et al. Rapid detection of fetal aneuploidy using proteomics approaches on amniotic fluid supernatant. Prenat Diagn. 2005;25:559–566
  8. Mathews T, Verma RS. Enhancement of amniotic fluid cell growth for genetic amniocentesis. Clin Genet. 1991;40:190–193
  9. Wu CC, Chien KY, Tsang NM, Chang KP, Hao SP, Tsao CH, et al. Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model. Proteomics. 2005;5:3173–3182
  10. Wang TH, Chan YH, Chen CW, Kung WH, Lee YS, Wang ST, et al. Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways. Oncogene. 2006;25:4857–4866
  11. Wang TH, Chang CL, Wu HM, Chiu YM, Chen CK, Wang HS. Insulin-like growth factor-II (IGF-II), IGF-binding protein-3 (IGFBP-3), and IGFBP-4 in follicular fluid are associated with oocyte maturation and embryo development. Fertil Steril. 2006;86:1392–1401
  12. Nikolsky Y, Ekins S, Nikolskaya T, Bugrim A. A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol Lett. 2005;158:20–29
  13. Tsai MS, Hwang SM, Chen KD, Lee YS, Hsu LW, Chang YJ, et al. Functional network analysis on the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells. 2007;25:2511–2523
  14. Chao A, Wang TH, Lee YS, Hong JH, Tsai CN, Chen CK, et al. Analysis of functional groups of differentially expressed genes in the peripheral blood of patients with cervical cancer undergoing concurrent chemoradiation treatment. Radiat Res. 2008;169:76–86
  15. Mason CW, Swaan PW, Weiner CP. Identification of interactive gene networks: a novel approach in gene array profiling of myometrial events during guinea pig pregnancy. Am J Obstet Gynecol. 2006;194:1513–1523
  16. Carr JM, Trygubenko SA, Wales DJ. Finding pathways between distant local minima. J Chem Phys. 2005;122:234903–234909
  17. Ekins S, Bugrim A, Brovold L, Kirillov E, Nikolsky Y, Rakhmatulin E, et al. Algorithms for network analysis in systems-ADME/Tox using the MetaCore and MetaDrug platforms. Xenobiotica. 2006;36:877–901
  18. Chen YC, Wang PW, Pan TL, Wallace CG, Chen CJ. Proteomic analysis of Down's syndrome patients with gout. Clin Chim Acta. 2006;369:89–94
  19. Shin JH, Gulesserian T, Verger E, Delabar JM, Lubec G. Protein dysregulation in mouse hippocampus polytransgenic for chromosome 21 structures in the Down Syndrome Critical Region. J Proteome Res. 2006;5:44–53
  20. Fountoulakis M, Gulesserian T, Lubec G. Overexpression of C1-tetrahydrofolate synthase in fetal Down syndrome brain. J Neural Transm Suppl. 2003;67:85–93
  21. Krapfenbauer K, Engidawork E, Cairns N, Fountoulakis M, Lubec G. Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res. 2003;967:152–160
  22. Bajo M, Fruehauf J, Kim SH, Fountoulakis M, Lubec G. Proteomic evaluation of intermediary metabolism enzyme proteins in fetal Down's syndrome cerebral cortex. Proteomics. 2002;2:1539–1546
  23. Kadota M, Nishigaki R, Wang CC, Toda T, Shirayoshi Y, Inoue T, et al. Proteomic signatures and aberrations of mouse embryonic stem cells containing a single human chromosome 21 in neuronal differentiation: an in vitro model of Down syndrome. Neuroscience. 2004;129:325–335
  24. Stewart CJ, Iles RK, Perrett D. The analysis of human amniotic fluid using capillary electrophoresis. Electrophoresis. 2001;22:1136–1142
  25. Salo MK, Solakivi-Jaakkola T, Kivimaki T, Nikkari T. Plasma lipids and lipoproteins in Down's syndrome. Scand J Clin Lab Invest. 1979;39:485–490
  26. Dorner K, Gaethke AS, Tolksdorf M, Schumann KP, Gustmann H. Cholesterol fractions and triglycerides in children and adults with Down's syndrome. Clin Chim Acta. 1984;142:307–311
  27. Pueschel SM, Craig WY, Haddow JE. Lipids and lipoproteins in persons with Down's syndrome. J Intellect Disabil Res. 1992;36:365–369
  28. Jay V, Chan FW, Becker LE. Dendritic arborization in the human fetus and infant with the trisomy 18 syndrome. Brain Res Dev Brain Res. 1990;54:291–294
  29. Seppala M, Taylor RN, Koistinen H, Koistinen R, Milgrom E. Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr Rev. 2002;23:401–430
  30. Bartelik S. [Concentration of serum proteins in children with down syndrome]. Wiad Lek. 1992;45:682–685
  31. Dorta-Contreras AJ, Barshatzky M, Noris-Garcia E, Serrano-Sanchez T. [Transthyretin levels in serum and cerebrospinal fluid sustain the nutrio-viral hypothesis of the Cuban epidemic neuropathy]. Rev Neurol. 2000;31:801–804
  32. Hodgkins PS, Prasher V, Farrar G, Armstrong R, Sturman S, Corbett J, et al. Reduced transferrin binding in Down syndrome: a route to senile plaque formation and dementia. Neuroreport. 1993;5:21–24
  33. Uehara S, Obara Y, Obara T, Funato T, Yaegashi N, Fukaya T, et al. Trisomy 18 mosaicism associated with secondary amenorrhea: ratios of mosaicism in different samples and complications. Clin Genet. 1996;49:91–94
  34. Sybert VP. Hypomelanosis of Ito: a description, not a diagnosis. J Invest Dermatol. 1994;103:141S–143S
  35. Lam WW, Kirk J, Manning N, Reardon W, Kelley RI, Fitzpatrick D. Decreased cholesterol synthesis as a possible aetiological factor in malformations of Trisomy 18. Eur J Med Genet. 2006;49:195–199
  36. Makrydimas G, Plachouras N, Thilaganathan B, Nicolaides KH. Abnormal immunological development in fetuses with trisomy 18. Prenat Diagn. 1994;14:239–241
  37. Zizka Z, Calda P, Fait T, Haakova L, Kvasnicka J, Viskova H. Prenatally diagnosable differences in the cellular immunity of fetuses with Down's and Edwards' syndrome. Fetal Diagn Ther. 2006;21:510–514
  38. Thilaganathan B, Meher-Homji NJ, Nicolaides KH. Maternal platelet size as a marker for fetal trisomies 18 and 13. Prenat Diagn. 1995;15:605–608
  39. Hohlfeld P, Forestier F, Kaplan C, Tissot JD, Daffos F. Fetal thrombocytopenia: a retrospective survey of 5,194 fetal blood samplings. Blood. 1994;84:1851–1856
  40. Freson K, Hashimoto H, Thys C, Wittevrongel C, Danloy S, Morita Y, et al. The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation. J Clin Invest. 2004;113:905–912
  41. Bocconi L, Nava S, Fogliani R, Nicolini U. Trisomy 21 is associated with hypercholesterolemia during intrauterine life. Am J Obstet Gynecol. 1997;176:540–543
  42. Diomede L, Salmona M, Albani D, Bianchi M, Bruno A, Salmona S, et al. Alteration of SREBP activation in liver of trisomy 21 fetuses. Biochem Biophys Res Commun. 1999;260:499–503
  43. Tansley GH, Burgess BL, Bryan MT, Su Y, Hirsch-Reinshagen V, Pearce J, et al. The cholesterol transporter ABCG1 modulates the subcellular distribution and proteolytic processing of {beta}-amyloid precursor protein. J Lipid Res. 2007;48:1022–1034
  44. Anneren G, Gebre-Medhin M. Trace elements and transport proteins in serum of children with Down syndrome and of healthy siblings living in the same environment. Hum Nutr Clin Nutr. 1987;41:291–299
  45. Elovaara I, Maury CP, Palo J. Serum amyloid A protein, albumin and prealbumin in Alzheimer's disease and in demented patients with Down's syndrome. Acta Neurol Scand. 1986;74:245–250
  46. Farrar G, Altmann P, Welch S, Wychrij O, Ghose B, Lejeune J, et al. Defective gallium-transferrin binding in Alzheimer disease and Down syndrome: possible mechanism for accumulation of aluminium in brain. Lancet. 1990;335:747–750
  47. Elovaara I. Proteins in serum and cerebrospinal fluid in demented patients with Down's syndrome. Acta Neurol Scand. 1984;69:302–305
  48. Chang KT, Min KT. Drosophila melanogaster homolog of Down syndrome critical region 1 is critical for mitochondrial function. Nat Neurosci. 2005;8:1577–1585
  49. Lee SH, Lee S, Jun HS, Jeong HJ, Cha WT, Cho YS, et al. Expression of the mitochondrial ATPase6 gene and Tfam in Down syndrome. Mol Cells. 2003;15:181–185

 T.-H.W. has nothing to disclose. A.-S.C. has nothing to disclose. J.-K.C. has nothing to disclose. A.C. has nothing to disclose. Y.-L.C. has nothing to disclose. P.-J.C. has nothing to disclose. S.-D.C. has nothing to disclose. H.-S.W. has nothing to disclose.

 Supported by the following grants: NSC 94-2314-B-182A-137 (S.-D.C.), NSC-95-2113-M-182A-001 (J.-K.C. and T.-H.W), and NSC-94-2314-B-182-050 (H.-S.W) from the National Science Council, Taiwan; as well as CMRPG 360031(S.-D.C.), CMRPG 330313 (T.-H.W), and CMRPG 340291 (H.-S.W) from Chang Gung Memorial Hospital.

 T.-H. Wang and A.-S. Chao contributed equally to this work.

PII: S0015-0282(08)01150-3

doi: 10.1016/j.fertnstert.2008.05.038

Fertility and Sterility
Volume 92, Issue 1 , Pages 96-107 , July 2009

Article Tools

* Image Usage & Resolution